WINDTREE THERAPEUTICS INC /DE/ Cash and Cash Equivalents, Period Increase (Decrease)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$5.78 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-13
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$5.78M.
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $18.14M, a 71.50% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$1.69M, a 84400.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $4.05M.
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for fiscal 2019 was $11.37M, a 22.06% increase from fiscal 2018.
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for fiscal 2018 was $9.32M.
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$5.99M.
- WINDTREE THERAPEUTICS INC /DE/ cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$41.57M, a 170.00% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 1 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | -$5.78M 10-Q · filed 2020-05-13 | $12.36M derived: sum of 2 quarters · filed 2020-05-13 | $10.68M derived: sum of 3 quarters · filed 2020-05-13 | $14.73M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2019-12-31 | $18.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $16.45M derived: sum of 2 quarters · filed 2020-04-03 | $20.51M derived: sum of 3 quarters · filed 2020-04-03 | $11.37M 10-K · filed 2020-04-03 | |
| 2019-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $2.37M derived: sum of 2 quarters · filed 2019-11-14 | -$6.77M 10-Q · filed 2019-11-14 | $3.81M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2019-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$5.08M 10-Q · filed 2019-08-14 | $5.50M derived: sum of 3 quarters · filed 2020-05-13 | $5.50M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2019-03-31 | -$9.13M 10-Q · filed 2020-05-13 | $1.44M derived: sum of 2 quarters · filed 2020-05-13 | $1.45M derived: sum of 3 quarters · filed 2020-05-13 | $230.00K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $10.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $10.58M derived: sum of 2 quarters · filed 2020-04-03 | $9.36M derived: sum of 3 quarters · filed 2020-04-03 | $9.32M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$1.21M derived: sum of 2 quarters · filed 2019-11-14 | -$1.26M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | -$1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$1.26M 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | -$46.00K 10-Q · filed 2019-05-20 | ||||
| 2016-12-31 | -$33.13M 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | -$7.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$17.02M derived: sum of 2 quarters · filed 2016-11-14 | -$26.34M 10-Q · filed 2016-11-14 | -$33.92M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2016-06-30 | -$9.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$18.39M 10-Q · filed 2016-08-10 | -$25.98M derived: sum of 3 quarters · filed 2017-03-31 | -$5.76M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2016-03-31 | -$9.32M 10-Q · filed 2016-05-12 | -$16.91M derived: sum of 2 quarters · filed 2017-03-31 | $3.31M derived: sum of 3 quarters · filed 2017-03-31 | -$6.18M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2015-12-31 | -$7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $12.63M derived: sum of 2 quarters · filed 2017-03-31 | $3.14M derived: sum of 3 quarters · filed 2017-03-31 | -$5.99M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $20.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $10.72M derived: sum of 2 quarters · filed 2016-11-14 | $1.60M 10-Q · filed 2016-11-14 | -$8.61M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | -$9.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$18.62M 10-Q · filed 2016-08-10 | -$28.82M derived: sum of 3 quarters · filed 2016-08-10 | -$39.47M derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | -$9.13M 10-Q · filed 2016-05-12 | -$19.33M derived: sum of 2 quarters · filed 2016-05-12 | -$29.97M derived: sum of 3 quarters · filed 2016-05-12 | -$40.36M derived: sum of 4 quarters · filed 2016-05-12 | |
| 2014-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$20.85M derived: sum of 2 quarters · filed 2016-03-29 | -$31.23M derived: sum of 3 quarters · filed 2016-03-29 | -$41.57M 10-K · filed 2016-03-29 | |
| 2014-09-30 | -$10.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$21.03M derived: sum of 2 quarters · filed 2015-11-05 | -$31.37M 10-Q · filed 2015-11-05 | $33.74M derived: sum of 4 quarters · filed 2015-11-05 | |
| 2014-06-30 | -$10.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$20.73M 10-Q · filed 2015-08-10 | $44.38M derived: sum of 3 quarters · filed 2015-08-10 | $34.30M derived: sum of 4 quarters · filed 2015-08-10 | |
| 2014-03-31 | -$10.34M 10-Q · filed 2015-05-11 | $54.77M derived: sum of 2 quarters · filed 2015-05-11 | $44.69M derived: sum of 3 quarters · filed 2015-05-11 | $49.57M derived: sum of 4 quarters · filed 2015-05-11 | |
| 2013-12-31 | $65.11M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $55.03M derived: sum of 2 quarters · filed 2015-03-16 | $59.91M derived: sum of 3 quarters · filed 2015-03-16 | $59.39M 10-K · filed 2015-03-16 | |
| 2013-09-30 | -$10.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$5.19M derived: sum of 2 quarters · filed 2014-11-07 | -$5.71M 10-Q · filed 2014-11-07 | -$14.89M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-06-30 | $4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $4.36M 10-Q · filed 2014-08-07 | -$4.81M derived: sum of 3 quarters · filed 2015-03-16 | -$14.76M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-03-31 | -$522.00K 10-Q · filed 2014-05-12 | -$9.69M derived: sum of 2 quarters · filed 2015-03-16 | -$19.64M derived: sum of 3 quarters · filed 2015-03-16 | -$28.43M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2012-12-31 | -$9.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$19.12M derived: sum of 2 quarters · filed 2015-03-16 | -$27.91M derived: sum of 3 quarters · filed 2015-03-16 | $16.70M 10-K · filed 2015-03-16 | |
| 2012-09-30 | -$9.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$18.74M derived: sum of 2 quarters · filed 2013-11-12 | $25.88M 10-Q · filed 2013-11-12 | $20.65M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-06-30 | -$8.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $35.82M 10-Q · filed 2013-08-08 | $30.60M derived: sum of 3 quarters · filed 2014-03-17 | $24.47M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-03-31 | $44.61M 10-Q · filed 2013-05-07 | $39.39M derived: sum of 2 quarters · filed 2014-03-17 | $33.26M derived: sum of 3 quarters · filed 2014-03-17 | $27.14M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2011-12-31 | -$5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$11.35M derived: sum of 2 quarters · filed 2014-03-17 | -$17.47M derived: sum of 3 quarters · filed 2014-03-17 | -$22.00K 10-K · filed 2014-03-17 | |
| 2011-09-30 | -$6.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$12.25M derived: sum of 2 quarters · filed 2012-11-14 | $5.20M 10-Q · filed 2012-11-14 | $757.00K derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-06-30 | -$6.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $11.33M 10-Q · filed 2012-08-14 | $6.89M derived: sum of 3 quarters · filed 2013-03-15 | -$1.78M derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-03-31 | $17.45M 10-Q · filed 2012-05-15 | $13.01M derived: sum of 2 quarters · filed 2013-03-15 | $4.34M derived: sum of 3 quarters · filed 2013-03-15 | ||
| 2010-12-31 | -$4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$13.11M derived: sum of 2 quarters · filed 2013-03-15 | -$5.53M 10-K · filed 2013-03-15 | ||
| 2010-09-30 | -$8.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$1.09M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $7.58M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |